calpeptin has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beke Debreceni, I; Czimmerer, Z; Fejes, Z; Gál Szabó, G; Káplár, M; Kappelmayer, J; Kunapuli, SP; Nagy, B; Penyige, A; Póliska, S | 1 |
| Butler, AE; Butler, PC; Costes, S; Daval, M; Gurlo, T; Haataja, L; Huang, CJ; Ryazantsev, S; Wu, X | 1 |
2 other study(ies) available for calpeptin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Blood Platelets; Calpain; Case-Control Studies; Circulating MicroRNA; Cross-Sectional Studies; Cysteine Proteinase Inhibitors; DEAD-box RNA Helicases; Diabetes Mellitus, Type 2; Dipeptides; Down-Regulation; Female; Humans; K562 Cells; Male; Megakaryocytes; Middle Aged; P-Selectin; Platelet Activation; Receptors, Purinergic P2Y12; Ribonuclease III; Time Factors; Transfection; Up-Regulation | 2017 |
Calcium-activated calpain-2 is a mediator of beta cell dysfunction and apoptosis in type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Amyloid; Animals; Apoptosis; Calcium; Calpain; Cell Line, Tumor; Cell Survival; Cytosol; Diabetes Mellitus, Type 2; Dipeptides; Enzyme Activation; Female; Humans; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Male; Middle Aged; Protein Transport; Rats; Recombinant Fusion Proteins; Spectrin | 2010 |